Swiss CBD overproduction: where does the surplus go – and how do we prevent synthetic-sprayed weed?

Switzerland produces more CBD than it consumes. An honest analysis: where the surplus actually goes, how high the risk of synthetic cannabinoids in exported flower is, why current regulation incentivises the grey market – and why regulated legalisation is the cleanest answer.

Switzerland has been producing far more CBD flower than its own market can absorb for years. A large share quietly leaks abroad – to street dealers, shady shop networks, sometimes "upgraded" with synthetic cannabinoids. That isn't just an economic problem; it's a moral one. And it has an honest answer.

How much CBD does Switzerland actually produce?

Official numbers are thin because much of the industry doesn't report. Industry estimates put annual Swiss output at 20 to 60 tonnes of CBD flower across indoor, greenhouse and outdoor. Domestic consumption – tobacco substitute, vape, extracts, oils – is a fraction of that.

Even on conservative math, this leaves a massive yearly surplus. That isn't a secret in the industry – it's the uncomfortable truth no one wants to discuss publicly.

Where does the flower actually go?

Some of it goes through legal channels: B2B to Swiss shops, EU partners for extraction (≤ 0.2 / 0.3 % THC), the tobacco industry for CBD cigarettes. A meaningful share – which the industry rarely talks about openly – moves through grey or black channels:

Is it morally OK to sell to street dealers abroad?

Our honest answer: No, not the way it currently works. Selling large volumes of Swiss CBD flower or pollinate to a foreign middleman without knowing what happens at the end of the chain makes you actively complicit in:

The classic excuse – "we only sell B2B, what happens after is not our problem" – is exactly that: an excuse. Anyone in this industry knows where the material is going.

How likely is it that exported flower is synthetic-treated?

Higher than most people think. European drug agencies (EUDA / EMCDDA), the Swiss Federal Office of Public Health and several independent labs have been warning for years about a clear pattern:

That's the dark side of the uncontrolled Swiss export pipeline: legally produced CBD becomes raw material for a highly dangerous end product on the EU black market.

The THC problem: many strains can't legally be sold at all

Many genetics grown in Switzerland fluctuate in THC content. A strain that tests just under 1 % in one batch may test just above in the next. Such batches can't be sold legally in Switzerland (< 1 % THC) or in the EU (≤ 0.3 % THC).

Three things happen to that material:

  1. Destruction – economically unviable for many small producers
  2. Re-declaration and grey-export – the current default
  3. Reprocessing into extracts where THC is technically removed – expensive, only realistic for bigger players

In other words: the current rulebook itself creates the incentive to move good material out of the country through grey channels.

The honest fix: legalise cannabis

You don't have to be a "pro-weed activist" to see that the current situation helps no one – except those profiting from the grey zone. The clean fix is regulated legalisation:

What we do at CannabisClub.ch in practice

Bottom line

Switzerland produces too much CBD, regulation incentivises a grey market, and at the end of the chain there are often street dealers with synthetic-treated flower in Berlin, Paris or Milan. Anyone in the industry pretending not to know is lying to themselves.

We believe in a different path: regulated legalisation, transparent quality, community instead of black market. If that resonates, check out our concept or read how we're working against the black market through legal access.